Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Return on Tangible Equity 2010-2023 | BMY

Current and historical return on tangible equity values for Bristol Myers Squibb (BMY) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Bristol Myers Squibb Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-09-30 $8.29B $-21.04B -36.74%
2023-06-30 $7.96B $-20.44B -33.27%
2023-03-31 $7.31B $-22.85B -29.02%
2022-12-31 $6.33B $-25.89B -23.68%
2022-09-30 $6.68B $-26.56B -24.73%
2022-06-30 $6.62B $-25.48B -24.15%
2022-03-31 $6.25B $-28.96B -21.58%
2021-12-31 $6.99B $-27.02B -23.20%
2021-09-30 $-5.41B $-28.17B 16.70%
2021-06-30 $-5.08B $-31.72B 15.84%
2021-03-31 $-6.22B $-33.67B 19.56%
2020-12-31 $-9.02B $-35.91B 28.26%
2020-09-30 $-0.04B $-26.99B 0.14%
2020-06-30 $-0.56B $-30.59B 2.52%
2020-03-31 $0.95B $-34.14B -7.63%
2019-12-31 $3.44B $-34.76B -168.95%
2019-09-30 $5.66B $10.24B 68.31%
2019-06-30 $6.20B $8.62B 86.05%
2019-03-31 $5.14B $7.76B 82.78%
2018-12-31 $4.92B $6.50B 89.34%
2018-09-30 $1.43B $5.96B 29.67%
2018-06-30 $0.38B $4.65B 7.45%
2018-03-31 $0.92B $4.93B 16.52%
2017-12-31 $1.01B $3.77B 16.99%
2017-09-30 $4.23B $6.84B 60.37%
2017-06-30 $4.59B $6.72B 63.88%
2017-03-31 $4.84B $6.38B 67.11%
2016-12-31 $4.46B $8.09B 62.04%
2016-09-30 $3.37B $7.53B 50.29%
2016-06-30 $2.87B $6.82B 44.12%
2016-03-31 $1.57B $6.30B 24.26%
2015-12-31 $1.57B $6.12B 23.53%
2015-09-30 $1.78B $6.78B 26.60%
2015-06-30 $1.79B $6.75B 27.17%
2015-03-31 $2.25B $6.96B 34.55%
2014-12-31 $2.00B $6.20B 31.55%
2014-09-30 $2.72B $6.44B 43.43%
2014-06-30 $2.69B $6.49B 61.51%
2014-03-31 $2.89B $6.28B 123.71%
2013-12-31 $2.56B $5.82B 1850.54%
2013-09-30 $2.76B $-1.11B -137.31%
2013-06-30 $1.36B $-1.64B -55.71%
2013-03-31 $1.47B $-2.52B -160.20%
2012-12-31 $1.96B $-2.78B 224.85%
2012-09-30 $1.89B $-2.82B 56.20%
2012-06-30 $3.56B $4.44B 59.61%
2012-03-31 $3.82B $4.63B 56.24%
2011-12-31 $3.70B $7.16B 49.52%
2011-09-30 $3.32B $7.68B 44.64%
2011-06-30 $3.30B $7.69B 44.03%
2011-03-31 $3.33B $7.37B 44.54%
2010-12-31 $3.09B $7.04B 41.55%
2010-09-30 $10.63B $7.92B 144.49%
2010-06-30 $10.64B $7.59B 153.87%
2010-03-31 $10.70B $7.20B 152.23%
2009-12-31 $10.59B $6.70B 150.77%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $99.500B $46.159B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.010B 14.72
Gilead Sciences (GILD) United States $94.699B 11.39
Vertex Pharmaceuticals (VRTX) United States $91.952B 27.03
Regeneron Pharmaceuticals (REGN) United States $87.336B 20.90
CSL (CSLLY) Australia $81.918B 0.00
GSK (GSK) United Kingdom $71.888B 9.31
Seagen (SGEN) United States $39.764B 0.00
Biogen (BIIB) United States $33.343B 14.54
Moderna (MRNA) United States $30.106B 0.00
Argenex SE (ARGX) Netherlands $28.908B 0.00
BioNTech SE (BNTX) Germany $23.493B 8.57
Genmab (GMAB) Denmark $21.446B 34.53
Alnylam Pharmaceuticals (ALNY) United States $20.739B 0.00
BeiGene (BGNE) Cayman Islands $17.895B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.488B 79.57
Illumina (ILMN) United States $15.500B 112.19
Incyte (INCY) United States $12.260B 23.79
Exact Sciences (EXAS) United States $12.169B 0.00
Legend Biotech (LEGN) United States $10.956B 0.00
Bio-Techne Corp (TECH) United States $10.057B 36.13
Verona Pharma American Depositary Share (VRNA) United Kingdom $9.363B 0.00
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $9.307B 0.00
QIAGEN (QGEN) Netherlands $9.088B 19.44
Bio-Rad Laboratories (BIO.B) United States $8.746B 25.05
Repligen (RGEN) United States $8.690B 74.83
Sarepta Therapeutics (SRPT) United States $7.770B 0.00
Roivant Sciences (ROIV) United Kingdom $7.075B 0.00
Karuna Therapeutics (KRTX) United States $6.796B 0.00
Exelixis (EXEL) United States $6.509B 74.75
Swedish Orphan Biovitrum (BIOVF) Sweden $6.213B 21.93
Apellis Pharmaceuticals (APLS) United States $5.866B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.733B 0.00
Intra-Cellular Therapies (ITCI) United States $5.636B 0.00
Ascendis Pharma (ASND) Denmark $5.406B 0.00
Halozyme Therapeutics (HALO) United States $5.285B 17.86
Vaxcyte (PCVX) United States $4.892B 0.00
Immunovant (IMVT) United States $4.890B 0.00
Alkermes (ALKS) Ireland $4.035B 31.82
Blueprint Medicines (BPMC) United States $4.005B 0.00
Mirati Therapeutics (MRTX) United States $3.963B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.763B 0.00
Insmed (INSM) United States $3.522B 0.00
Nuvalent (NUVL) United States $3.441B 0.00
Ginkgo Bioworks Holdings (DNA) United States $3.241B 0.00
Amicus Therapeutics (FOLD) United States $3.237B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.231B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.230B 0.00
Cytokinetics (CYTK) United States $3.168B 0.00
Krystal Biotech (KRYS) United States $2.955B 0.00
Fortrea Holdings (FTRE) United States $2.870B 0.00
Axsome Therapeutics (AXSM) United States $2.841B 0.00
Guardant Health (GH) United States $2.820B 0.00
Zai Lab (ZLAB) China $2.794B 0.00
Intellia Therapeutics (NTLA) United States $2.712B 0.00
ImmunityBio (IBRX) United States $2.704B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.665B 0.00
Denali Therapeutics (DNLI) United States $2.652B 0.00
Arcellx (ACLX) United States $2.562B 0.00
Beam Therapeutics (BEAM) United States $2.507B 0.00
NeoGenomics (NEO) United States $2.487B 0.00
Galapagos (GLPG) Belgium $2.464B 0.00
Biohaven (BHVN) United States $2.455B 0.00
Certara (CERT) United States $2.351B 39.76
Immunocore Holdings (IMCR) United Kingdom $2.227B 0.00
Zealand Pharma (ZLDPF) Denmark $2.146B 0.00
Structure Therapeutics (GPCR) United States $2.046B 0.00
IDEAYA Biosciences (IDYA) United States $1.987B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.984B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.970B 0.00
Xenon Pharmaceuticals (XENE) Canada $1.903B 0.00
Prothena (PRTA) Ireland $1.830B 0.00
Neumora Therapeutics (NMRA) United States $1.810B 0.00
Dynavax Technologies (DVAX) United States $1.768B 35.08
Bavarian Nordic (BVNRY) Denmark $1.752B 10.56
Vericel (VCEL) United States $1.750B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.627B 10.36
Mirum Pharmaceuticals (MIRM) United States $1.496B 0.00
Myriad Genetics (MYGN) United States $1.485B 0.00
POINT Biopharma Global (PNT) United States $1.461B 15.23
Twist Bioscience (TWST) United States $1.420B 0.00
Iovance Biotherapeutics (IOVA) United States $1.405B 0.00
Merus (MRUS) Netherlands $1.403B 0.00
RayzeBio (RYZB) United States $1.396B 0.00
SpringWorks Therapeutics (SWTX) United States $1.391B 0.00
AbCellera Biologics (ABCL) Canada $1.335B 0.00
Vir Biotechnology (VIR) United States $1.318B 0.00
Celldex Therapeutics (CLDX) United States $1.287B 0.00
CureVac (CVAC) Germany $1.247B 0.00
Disc Medicine (IRON) United States $1.234B 0.00
Morphic Holding (MORF) United States $1.198B 0.00
Arvinas (ARVN) United States $1.198B 0.00
Viking Therapeutics (VKTX) United States $1.177B 0.00
Kymera Therapeutics (KYMR) United States $1.159B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.114B 0.00
Geron (GERN) United States $1.092B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.074B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.055B 0.00
Inhibrx (INBX) United States $1.053B 0.00
ANI Pharmaceuticals (ANIP) United States $1.048B 13.98
Arcus Biosciences (RCUS) United States $1.045B 0.00
Belite Bio (BLTE) United States $1.041B 0.00
MannKind (MNKD) United States $1.014B 0.00
Ligand Pharmaceuticals (LGND) United States $1.009B 16.56
Protagonist Therapeutics (PTGX) United States $0.994B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.989B 0.00
Northwest Biotherapeutics (NWBO) United States $0.964B 0.00
Akero Therapeutics (AKRO) United States $0.929B 0.00
Apogee Therapeutics (APGE) United States $0.913B 0.00
ADMA Biologics Inc (ADMA) United States $0.911B 0.00
Keros Therapeutics (KROS) United States $0.899B 0.00
Editas Medicine (EDIT) United States $0.885B 0.00
REGENXBIO (RGNX) United States $0.881B 0.00
Olema Pharmaceuticals (OLMA) United States $0.874B 0.00
ACELYRIN, INC (SLRN) United States $0.866B 0.00
Pliant Therapeutics (PLRX) United States $0.860B 0.00
Viridian Therapeutics (VRDN) United States $0.851B 0.00
Scholar Rock Holding (SRRK) United States $0.848B 0.00
Sana Biotechnology (SANA) United States $0.848B 0.00
MiMedx (MDXG) United States $0.834B 0.00
Cytek Biosciences (CTKB) United States $0.824B 0.00
Pharming Group (PHAR) Netherlands $0.780B 0.00
Tango Therapeutics (TNGX) United States $0.776B 0.00
Cabaletta Bio (CABA) United States $0.769B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.767B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.766B 0.00
Pharming Group (PHGUF) Netherlands $0.744B 0.00
Kura Oncology (KURA) United States $0.709B 0.00
Novavax (NVAX) United States $0.677B 0.00
Prime Medicine (PRME) United States $0.676B 0.00
HilleVax (HLVX) United States $0.673B 0.00
Immatics (IMTX) Germany $0.659B 0.00
Revance Therapeutics (RVNC) United States $0.656B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.652B 9.31
Cogent Biosciences (COGT) United States $0.649B 0.00
PureTech Health (PRTC) United States $0.648B 0.00
Pharma Mar (PHMMF) Spain $0.645B 0.00
Sinovac Biotech (SVA) China $0.644B 0.00
Adaptive Biotechnologies (ADPT) United States $0.643B 0.00
Ambrx Biopharma (AMAM) United States $0.612B 0.00
Replimune (REPL) United States $0.601B 0.00
Vera Therapeutics (VERA) United States $0.600B 0.00
89BIO (ETNB) United States $0.585B 0.00
Zymeworks (ZYME) United States $0.585B 2.69
Tarsus Pharmaceuticals (TARS) United States $0.579B 0.00
Anavex Life Sciences (AVXL) United States $0.574B 0.00
Entrada Therapeutics (TRDA) United States $0.544B 0.00
Castle Biosciences (CSTL) United States $0.540B 0.00
Icosavax (ICVX) United States $0.538B 0.00
WAVE Life Sciences (WVE) Singapore $0.515B 0.00
Allogene Therapeutics (ALLO) United States $0.503B 0.00
Caribou Biosciences (CRBU) United States $0.492B 0.00
ALX Oncology Holdings (ALXO) United States $0.488B 0.00
AN2 Therapeutics (ANTX) United States $0.487B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.486B 0.00
Tyra Biosciences (TYRA) United States $0.485B 0.00
Rapt Therapeutics (RAPT) United States $0.479B 0.00
MaxCyte (MXCT) United States $0.466B 0.00
LianBio (LIAN) United States $0.443B 0.00
Avidity Biosciences (RNA) United States $0.442B 0.00
23andMe Holding (ME) United States $0.434B 0.00
Travere Therapeutics (TVTX) United States $0.432B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.427B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.424B 0.00
Liquidia Technologies (LQDA) United States $0.422B 0.00
Bluebird Bio (BLUE) United States $0.419B 0.00
Janux Therapeutics (JANX) United States $0.418B 0.00
Alector (ALEC) United States $0.414B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.409B 0.00
Edgewise Therapeutics (EWTX) United States $0.408B 0.00
Aerovate Therapeutics (AVTE) United States $0.401B 0.00
Oric Pharmaceuticals (ORIC) United States $0.390B 0.00
AnaptysBio (ANAB) United States $0.386B 0.00
Cullinan Oncology (CGEM) United States $0.375B 0.00
Biomea Fusion (BMEA) United States $0.368B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.365B 0.00
ITeos Therapeutics (ITOS) United States $0.365B 0.00
Adlai Nortye (ANL) Cayman Islands $0.363B 0.00
MeiraGTx Holdings (MGTX) United States $0.360B 0.00
Avid Bioservices (CDMO) United States $0.359B 0.00
Gracell Biotechnologies (GRCL) China $0.359B 0.00
Oculis Holding AG (OCS) Switzerland $0.350B 0.00
IGM Biosciences (IGMS) United States $0.349B 0.00
Nautilus Biotechnology (NAUT) United States $0.347B 0.00
Erasca (ERAS) United States $0.340B 0.00
UniQure (QURE) Netherlands $0.333B 0.00
Immunome (IMNM) United States $0.333B 0.00
Amarin (AMRN) Ireland $0.319B 0.00
Aura Biosciences (AURA) United States $0.318B 0.00
Celcuity (CELC) United States $0.317B 0.00
Nurix Therapeutics (NRIX) United States $0.316B 0.00
Arbutus Biopharma (ABUS) United States $0.309B 0.00
Anika Therapeutics (ANIK) United States $0.302B 0.00
Precigen (PGEN) United States $0.301B 0.00
Voyager Therapeutics (VYGR) United States $0.301B 5.56
Nuvation Bio (NUVB) United States $0.296B 0.00
Urogen Pharma (URGN) United States $0.292B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.289B 0.00
Fulcrum Therapeutics (FULC) United States $0.287B 0.00
Genelux (GNLX) United States $0.286B 0.00
Agenus (AGEN) United States $0.283B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.274B 0.00
Third Harmonic Bio (THRD) United States $0.272B 0.00
AC Immune (ACIU) Switzerland $0.267B 0.00
Humacyte (HUMA) United States $0.266B 0.00
Mineralys Therapeutics (MLYS) United States $0.264B 0.00
Poseida Therapeutics (PSTX) United States $0.262B 0.00
Fate Therapeutics (FATE) United States $0.256B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.253B 0.00
Atea Pharmaceuticals (AVIR) United States $0.251B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.250B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.241B 0.00
Inozyme Pharma (INZY) United States $0.241B 0.00
Ovid Therapeutics (OVID) United States $0.233B 0.00
Terns Pharmaceuticals (TERN) United States $0.232B 0.00
Coherus BioSciences (CHRS) United States $0.231B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.229B 0.00
Lifecore Biomedical (LFCR) United States $0.225B 0.00
TScan Therapeutics (TCRX) United States $0.220B 0.00
Repare Therapeutics (RPTX) Canada $0.217B 0.00
Compass Therapeutics (CMPX) United States $0.215B 0.00
Akoya Biosciences (AKYA) United States $0.215B 0.00
Kamada (KMDA) Israel $0.212B 18.88
Inventiva S.A (IVA) France $0.208B 0.00
CorMedix Inc (CRMD) United States $0.207B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.206B 17.05
Innate Pharma S.A (IPHA) France $0.202B 0.00
ScPharmaceuticals (SCPH) United States $0.201B 0.00
PDS Biotechnology (PDSB) United States $0.196B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.195B 0.00
Mersana Therapeutics (MRSN) United States $0.193B 0.00
Renovaro Biosciences (RENB) United States $0.193B 0.00
Zura Bio (ZURA) United States $0.193B 0.00
Gossamer Bio (GOSS) United States $0.189B 0.00
Mesoblast (MESO) Australia $0.189B 0.00
Stoke Therapeutics (STOK) United States $0.186B 0.00
Puma Biotechnology (PBYI) United States $0.185B 48.63
Merrimack Pharmaceuticals (MACK) United States $0.183B 0.00
Alimera Sciences (ALIM) United States $0.179B 0.00
XOMA (XOMA) United States $0.175B 0.00
Cartesian Therapeutics (RNAC) United States $0.174B 0.00
Cellectis S.A (CLLS) France $0.172B 0.00
Dianthus Therapeutics (DNTH) United States $0.172B 0.00
Scilex Holding (SCLX) United States $0.172B 0.00
Sutro Biopharma (STRO) United States $0.169B 0.00
Allakos (ALLK) United States $0.167B 0.00
Adocia (ADOCY) France $0.166B 0.00
Invivyd (IVVD) United States $0.165B 0.00
GENFIT S.A (GNFT) France $0.164B 0.00
Prima BioMed (IMMP) Australia $0.164B 0.00
DBV Technologies S.A (DBVT) France $0.164B 0.00
Immuneering (IMRX) United States $0.163B 0.00
Verastem (VSTM) United States $0.163B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.163B 0.00
Praxis Precision Medicines (PRAX) United States $0.158B 0.00
Molecular Partners AG (MOLN) Switzerland $0.158B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.156B 0.00
Applied Therapeutics (APLT) United States $0.154B 0.00
Theseus Pharmaceuticals (THRX) United States $0.149B 0.00
Nuvectis Pharma (NVCT) United States $0.144B 0.00
Greenwich LifeSciences (GLSI) United States $0.141B 0.00
Ventyx Biosciences (VTYX) United States $0.139B 0.00
Codexis (CDXS) United States $0.139B 0.00
Annexon (ANNX) United States $0.137B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.137B 0.00
Graphite Bio (GRPH) United States $0.136B 0.00
Absci (ABSI) United States $0.136B 0.00
INmune Bio (INMB) United States $0.135B 0.00
EnGene Holdings (ENGN) United States $0.134B 0.00
X4 Pharmaceuticals (XFOR) United States $0.134B 0.00
Vigil Neuroscience (VIGL) United States $0.131B 0.00
I-Mab (IMAB) China $0.130B 0.00
Nkarta (NKTX) United States $0.128B 0.00
Tenaya Therapeutics (TNYA) United States $0.128B 0.00
Astria Therapeutics (ATXS) United States $0.128B 0.00
Kodiak Sciences (KOD) United States $0.128B 0.00
Gritstone Bio (GRTS) United States $0.126B 0.00
Vaxxinity (VAXX) United States $0.125B 0.00
Seres Therapeutics (MCRB) United States $0.125B 0.00
Design Therapeutics (DSGN) United States $0.125B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.122B 0.00
TELA Bio (TELA) United States $0.119B 0.00
Oncolytics Biotech (ONCY) Canada $0.117B 0.00
Aadi Bioscience (AADI) United States $0.117B 0.00
Genetron Holdings (GTH) China $0.116B 0.00
Inovio Pharmaceuticals (INO) United States $0.115B 0.00
Vor Biopharma (VOR) $0.115B 0.00
Oncobiologics (OTLK) United States $0.115B 0.00
Connect Biopharma Holdings (CNTB) United States $0.113B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.113B 0.00
Opthea (OPT) Australia $0.112B 0.00
BioXcel Therapeutics (BTAI) United States $0.112B 0.00
Seer (SEER) United States $0.112B 0.00
XBiotech (XBIT) United States $0.111B 0.00
PepGen (PEPG) United States $0.111B 0.00
Omega Therapeutics (OMGA) United States $0.110B 0.00
Cue Biopharma (CUE) United States $0.110B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.109B 0.00
ChromaDex (CDXC) United States $0.109B 0.00
Emergent Biosolutions (EBS) United States $0.109B 0.00
Kinnate Biopharma (KNTE) United States $0.108B 0.00
Ocugen (OCGN) United States $0.105B 0.00
Abeona Therapeutics (ABEO) United States $0.105B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.103B 0.00
MediciNova (MNOV) United States $0.101B 0.00
Rani Therapeutics Holdings (RANI) United States $0.100B 0.00
Genenta Science S.p.A (GNTA) Italy $0.099B 0.00
Shattuck Labs (STTK) United States $0.095B 0.00
VistaGen Therapeutics (VTGN) United States $0.095B 0.00
CytomX Therapeutics (CTMX) United States $0.093B 0.00
Rallybio (RLYB) United States $0.093B 0.00
Adverum Biotechnologies (ADVM) United States $0.092B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.092B 0.00
DiaMedica Therapeutics (DMAC) United States $0.092B 0.00
Miromatrix Medical (MIRO) United States $0.092B 0.00
Werewolf Therapeutics (HOWL) United States $0.089B 0.00
Eton Pharmaceuticals (ETON) United States $0.088B 34.45
2seventy Bio (TSVT) United States $0.088B 0.00
Immix Biopharma (IMMX) United States $0.088B 0.00
G1 Therapeutics (GTHX) United States $0.086B 0.00
C4 Therapeutics (CCCC) United States $0.083B 0.00
Trevi Therapeutics (TRVI) United States $0.083B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
China Health Industries Holdings (CHHE) China $0.082B 0.00
BioAtla (BCAB) United States $0.080B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.076B 0.00
Sangamo Therapeutics (SGMO) United States $0.074B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.074B 0.00
Jasper Therapeutics (JSPR) United States $0.072B 0.00
BRIACELL THERAP (BCTX) Canada $0.071B 0.00
Affimed (AFMD) Germany $0.071B 0.00
Kronos Bio (KRON) United States $0.070B 0.00
Turnstone Biologics (TSBX) United States $0.070B 0.00
Apollomics (APLM) Taiwan $0.069B 0.00
ATyr Pharma (LIFE) United States $0.069B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.069B 0.00
InflaRx (IFRX) Germany $0.068B 0.00
Cidara Therapeutics (CDTX) United States $0.068B 0.00
Ocuphire Pharma (OCUP) United States $0.066B 2.21
Spero Therapeutics (SPRO) United States $0.065B 13.67
IO Biotech (IOBT) Denmark $0.065B 0.00
Kezar Life Sciences (KZR) United States $0.064B 0.00
Sagimet Biosciences (SGMT) United States $0.064B 0.00
Enzo Biochem (ENZ) United States $0.064B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.062B 0.00
Annovis Bio (ANVS) United States $0.062B 0.00
Clearside Biomedical (CLSD) United States $0.061B 0.00
Clene (CLNN) United States $0.060B 0.00
Syros Pharmaceuticals (SYRS) United States $0.060B 0.00
Athira Pharma (ATHA) United States $0.060B 0.00
Adagene (ADAG) China $0.060B 0.00
Alpha Teknova (TKNO) United States $0.060B 0.00
Eyenovia (EYEN) United States $0.060B 0.00
YS Biopharma (YS) China $0.059B 0.79
Tiziana Life Sciences (TLSA) United Kingdom $0.058B 0.00
Cara Therapeutics (CARA) United States $0.058B 0.00
Atara Biotherapeutics (ATRA) United States $0.057B 0.00
Bionano Genomics (BNGO) United States $0.057B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.056B 0.00
Compugen (CGEN) Israel $0.056B 0.00
AVROBIO (AVRO) United States $0.056B 0.00
CervoMed (CRVO) United States $0.056B 0.00
Spruce Biosciences (SPRB) United States $0.055B 0.00
Coya Therapeutics (COYA) United States $0.055B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.055B 0.00
Aligos Therapeutics (ALGS) United States $0.054B 0.00
Precision BioSciences (DTIL) United States $0.053B 0.00
Leap Therapeutics (LPTX) United States $0.053B 0.00
Dyadic (DYAI) United States $0.052B 0.00
NGM Biopharmaceuticals (NGM) United States $0.052B 0.00
Cardiff Oncology (CRDF) United States $0.052B 0.00
Elicio Therapeutics (ELTX) United States $0.052B 0.00
Beyond Air (XAIR) United States $0.051B 0.00
Adicet Bio (ACET) United States $0.051B 0.00
Immunic (IMUX) United States $0.050B 0.00
OKYO Pharma (OKYO) $0.050B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.050B 0.00
Curis (CRIS) United States $0.050B 0.00
Instil Bio (TIL) United States $0.049B 0.00
Checkpoint Therapeutics (CKPT) United States $0.049B 0.00
Solid Biosciences (SLDB) United States $0.048B 0.00
Longeveron (LGVN) United States $0.046B 0.00
Lantern Pharma (LTRN) United States $0.044B 0.00
SAB Biotherapeutics (SABS) United States $0.044B 0.00
Prenetics Global (PRE) Cayman Islands $0.043B 52.27
HOOKIPA Pharma (HOOK) United States $0.043B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.043B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.040B 0.00
Rain Oncology (RAIN) United States $0.040B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.040B 0.00
Celularity (CELU) United States $0.039B 0.00
HCW Biologics (HCWB) United States $0.039B 0.00
Quince Therapeutics (QNCX) United States $0.038B 0.00
Gyre Therapeutics (GYRE) United States $0.037B 0.00
Ocean Biomedical (OCEA) United States $0.037B 0.00
VTv Therapeutics (VTVT) United States $0.037B 0.00
MiNK Therapeutics (INKT) United States $0.037B 0.00
BeyondSpring (BYSI) United States $0.036B 0.00
Bolt Biotherapeutics (BOLT) United States $0.035B 0.00
NextCure (NXTC) United States $0.035B 0.00
Passage Bio (PASG) United States $0.035B 0.00
Dare Bioscience (DARE) United States $0.034B 0.00
Xilio Therapeutics (XLO) United States $0.033B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.033B 0.00
Theratechnologies (THTX) Canada $0.033B 0.00
Kineta (KA) United States $0.033B 0.00
Biora Therapeutics (BIOR) United States $0.032B 0.00
Cognition Therapeutics (CGTX) United States $0.032B 0.00
Galena Biopharma (SLS) United States $0.031B 0.00
Neoleukin Therapeutics (NLTX) United States $0.031B 0.00
Cyclo Therapeutics (CYTH) United States $0.031B 0.00
Science 37 Holdings (SNCE) United States $0.030B 0.00
Rezolute (RZLT) United States $0.030B 0.00
NKGen Biotech (NKGN) United States $0.030B 0.00
UNITY Biotechnology (UBX) United States $0.030B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.030B 0.00
Intensity Therapeutics (INTS) United States $0.029B 0.00
IN8bio (INAB) United States $0.028B 0.00
Gamida Cell (GMDA) United States $0.026B 0.00
Elutia (ELUT) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.026B 0.00
Candel Therapeutics (CADL) United States $0.026B 0.00
Portage Biotech (PRTG) $0.025B 0.00
Fortress Biotech (FBIO) United States $0.025B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.025B 0.00
Freeline Therapeutics Holdings (FRLN) United Kingdom $0.025B 0.00
Lumos Pharma (LUMO) United States $0.024B 0.00
Pluri (PLUR) Israel $0.023B 0.00
Purple Biotech (PPBT) Israel $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
NuCana (NCNA) United Kingdom $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Aptose Biosciences (APTO) Canada $0.021B 0.00
Elevation Oncology (ELEV) United States $0.020B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Lisata Therapeutics (LSTA) United States $0.019B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.018B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.018B 0.00
CalciMedica (CALC) United States $0.018B 0.00
Forte Biosciences (FBRX) United States $0.018B 0.00
Equillium (EQ) United States $0.018B 0.00
Axcella Health (AXLA) United States $0.017B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.017B 0.00
Cocrystal Pharma (COCP) United States $0.017B 0.00
Bionomics (BNOX) Australia $0.017B 0.00
VBI Vaccines (VBIV) United States $0.016B 0.00
Senti Biosciences (SNTI) United States $0.016B 0.00
Moleculin Biotech (MBRX) United States $0.016B 0.00
KALA BIO (KALA) United States $0.016B 0.00
Galecto (GLTO) Denmark $0.016B 0.00
Orgenesis (ORGS) United States $0.016B 0.00
PHAXIAM Therapeutics S.A (PHXM) France $0.016B 0.00
Seelos Therapeutics (SEEL) United States $0.016B 0.00
TFF Pharmaceuticals (TFFP) United States $0.016B 0.00
BioCardia (BCDA) United States $0.016B 0.00
Sensei Biotherapeutics (SNSE) United States $0.016B 0.00
GENPREX (GNPX) United States $0.015B 0.00
Vincerx Pharma (VINC) United States $0.015B 0.00
Femasys (FEMY) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Virios Therapeutics (VIRI) United States $0.014B 0.00
Aprea Therapeutics (APRE) United States $0.014B 0.00
Mustang Bio (MBIO) United States $0.014B 0.00
Mainz Biomed (MYNZ) Germany $0.014B 0.00
BioAffinity Technologies (BIAF) United States $0.014B 0.00
Aytu BioPharma (AYTU) United States $0.013B 0.00
Talis Biomedical (TLIS) United States $0.013B 0.00
CNS Pharmaceuticals (CNSP) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Promis Neurosciences (PMN) Canada $0.012B 0.00
Landos Biopharma (LABP) United States $0.012B 0.00
Acorda Therapeutics (ACOR) United States $0.012B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.012B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.012B 0.00
Vaccinex (VCNX) United States $0.011B 0.00
Organovo Holdings (ONVO) United States $0.011B 0.00
Evelo Biosciences (EVLO) United States $0.011B 0.00
ARAVIVE, INC (ARAV) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Lexaria Bioscience (LEXX) Canada $0.010B 0.00
GT Biopharma (GTBP) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Telesis Bio (TBIO) United States $0.009B 0.00
Atreca (BCEL) United States $0.009B 0.00
Edesa Biotech (EDSA) Canada $0.009B 0.00
Trevena (TRVN) United States $0.009B 0.00
Alzamend Neuro (ALZN) United States $0.009B 0.00
Benitec Biopharma (BNTC) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Imunon (IMNN) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.009B 0.00
Aileron Therapeutics (ALRN) United States $0.009B 0.00
AEterna Zentaris (AEZS) Canada $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.008B 0.00
Applied Molecular Transport (AMTI) United States $0.008B 0.00
Notable Labs (NTBL) United States $0.008B 0.00
Galera Therapeutics (GRTX) United States $0.007B 0.00
Sunshine Biopharma (SBFM) Canada $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
RenovoRx (RNXT) United States $0.007B 0.00
Cingulate (CING) United States $0.006B 0.00
Blue Water Biotech (BWV) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.04
Chemomab Therapeutics (CMMB) Israel $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
TRACON Pharmaceuticals (TCON) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Biophytis SA (BPTS) France $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.33
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Monopar Therapeutics (MNPR) United States $0.004B 0.00
Invo BioScience (INVO) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
First Wave BioPharma (FWBI) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Aceragen (ACGN) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Estrella Immunopharma (ESLA) United States $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
Panbela Therapeutics (PBLA) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.15
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Cohbar (CWBR) United States $0.003B 0.00
NexImmune (NEXI) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Clovis Oncology (CLVSQ) United States $0.002B 0.00
ZIVO Bioscience (ZIVO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
PaxMedica (PXMD) United States $0.001B 0.00
Kintara Therapeutics (KTRA) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
MorphoSys AG (MOR) Germany $0.000B 15.03
ARCA Biopharma (ABIO) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
CARGO Therapeutics (CRGX) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
GH Research (GHRS) Ireland $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00